Terms: = Head and neck cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
303 results:
1. Multiple pathological fractures and muscle atrophy caused by a parathyroid carcinoma with postoperative hungry bone syndrome: A case report.
Liu Q; Zhang Y; Ma D; Gengzhi H; Maimaiti Y; Chen Q; Ma Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2047. PubMed ID: 38577726
[TBL] [Abstract] [Full Text] [Related]
2. Advances in testing for human papillomavirus -mediated head and neck cancer.
Mehanna H; Alemany L; von Buchwald C
Curr Opin Oncol; 2024 May; 36(3):143-146. PubMed ID: 38506408
[TBL] [Abstract] [Full Text] [Related]
3. Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma-A Systematic Review.
Devi P; Dwivedi R; Sankar R; Jain A; Gupta S; Gupta S
Head Neck Pathol; 2024 Mar; 18(1):21. PubMed ID: 38502412
[TBL] [Abstract] [Full Text] [Related]
4. Adenoid cystic carcinoma of the parotid and submandibular glands in children and young adults: A population-based study.
Phillips AL; Li C; Liang J; Sheyn A; Rastatter JC; Chelius DC; Orbach D; Richard C
Pediatr Blood Cancer; 2024 May; 71(5):e30928. PubMed ID: 38418934
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PandA trial.
Verschoor YL; van de Haar J; van den Berg JG; van Sandick JW; Kodach LL; van Dieren JM; Balduzzi S; Grootscholten C; IJsselsteijn ME; Veenhof AAFA; Hartemink KJ; Vollebergh MA; Jurdi A; Sharma S; Spickard E; Owers EC; Bartels-Rutten A; den Hartog P; de Miranda NFCC; van Leerdam ME; Haanen JBAG; Schumacher TN; Voest EE; Chalabi M
Nat Med; 2024 Feb; 30(2):519-530. PubMed ID: 38191613
[TBL] [Abstract] [Full Text] [Related]
6. Role of tumor budding and fibrotic cancer stroma in head and neck squamous cell carcinoma.
Mitha M; Aden D; Zaheer S; Alvi Y; Chintamani
Pathol Res Pract; 2024 Jan; 253():155052. PubMed ID: 38176309
[TBL] [Abstract] [Full Text] [Related]
7. Social Vulnerability Association with Thyroid cancer Disparities in the United States.
Fei-Zhang DJ; Verma R; Arimoto R; Lawrence AS; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
Thyroid; 2024 Feb; 34(2):225-233. PubMed ID: 38069566
[No Abstract] [Full Text] [Related]
8. NAD(P)H:quinone Oxidoreductase 1 Is Involved in AZ-1-induced Apoptotic Effects in Nasopharyngeal Carcinoma TW01 Cells.
Hsu CC; Wu YT; Yu SJ; Chen PJ; Lin SC; Liu FQ; Lo SC; Lin YL; Lan YY
Anticancer Res; 2023 Nov; 43(11):4879-4885. PubMed ID: 37910001
[TBL] [Abstract] [Full Text] [Related]
9. Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus head and neck Carcinoma: A Phase 2 Randomized Clinical Trial.
Wong SJ; Torres-Saavedra PA; Saba NF; Shenouda G; Bumpous JM; Wallace RE; Chung CH; El-Naggar AK; Gwede CK; Burtness B; Tennant PA; Dunlap NE; Redman R; Stokes WA; Rudra S; Mell LK; Sacco AG; Spencer SA; Nabell L; Yao M; Cury FL; Mitchell DL; Jones CU; Firat S; Contessa JN; Galloway T; Currey A; Harris J; Curran WJ; Le QT
JAMA Oncol; 2023 Nov; 9(11):1565-1573. PubMed ID: 37768670
[TBL] [Abstract] [Full Text] [Related]
10. Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral cancer Cells by Inhibiting the PI3K/AKT Pathway.
Yang CH; Chang YC; Hsu CC; Lin CH; Chen IJ; Wu YT; Lan YY
Anticancer Res; 2023 Sep; 43(9):4015-4022. PubMed ID: 37648299
[TBL] [Abstract] [Full Text] [Related]
11. Is unicentric familial papillary thyroid microcarcinoma different from multicentric?
Ríos A; Ruiz-Pardo J; Balaguer-Román A; Puñal JA; Moreno P; Mercader E; Ferrero E; Morlán MA; Martín J; Durán M; Bravo JM; Casanova D; Salvador-Egea MP; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
Endocrine; 2023 Dec; 82(3):613-621. PubMed ID: 37490266
[TBL] [Abstract] [Full Text] [Related]
12. Safety and tolerability of first-line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma.
Lee DH; Kim HR; Keam B; Kato K; Kuboki Y; Gao H; Yovine A; Robbins SH; Ahn MJ
Cancer Med; 2023 Aug; 12(15):16066-16075. PubMed ID: 37489066
[TBL] [Abstract] [Full Text] [Related]
13. Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker.
Mayer M; Nachtsheim L; Prinz J; Shabli S; Suchan M; Klußmann JP; Quaas A; Arolt C; Wolber P
Clin Exp Metastasis; 2023 Oct; 40(5):395-405. PubMed ID: 37480387
[TBL] [Abstract] [Full Text] [Related]
14. Spatially-aware clustering improves AJCC-8 risk stratification performance in oropharyngeal carcinomas.
Canahuate G; Wentzel A; Mohamed ASR; van Dijk LV; Vock DM; Elgohari B; Elhalawani H; Fuller CD; Marai GE
Oral Oncol; 2023 Sep; 144():106460. PubMed ID: 37390759
[TBL] [Abstract] [Full Text] [Related]
15. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
Yamauchi T; Fujishima F; Tsunokake J; Kunimitsu A; Akaishi R; Ozawa Y; Fukutomi T; Okamoto H; Sato C; Taniyama Y; Kamei T; Ichinohasama R; Sasano H
Int J Biol Markers; 2023 Jun; 38(2):105-113. PubMed ID: 37009661
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of Social Vulnerability in Pediatric head and neck cancer Care and prognosis in the United States.
Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
[TBL] [Abstract] [Full Text] [Related]
18. A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers.
Budhathoki S; Diergaarde B; Liu G; Olshan A; Ness A; Waterboer T; Virani S; Basta P; Bender N; Brenner N; Dudding T; Hayes N; Hope A; Huang SH; Hueniken K; Kanterewicz B; McKay JD; Pring M; Thomas S; Wisniewski K; Thomas S; Brhane Y; Agudo A; Alemany L; Lagiou A; Barzan L; Canova C; Conway DI; Healy CM; Holcatova I; Lagiou P; Macfarlane GJ; Macfarlane TV; Polesel J; Richiardi L; Robinson M; Znaor A; Brennan P; Hung RJ
Int J Cancer; 2023 May; 152(10):2069-2080. PubMed ID: 36694401
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of tumor budding and its correlation with histomorphological prognostic markers in oral squamous cell carcinoma and its association with the epithelial-mesenchymal transition process.
Yadav K; Singh T; Varma K; Bhargava M; Misra V
Indian J Pathol Microbiol; 2023; 66(1):3-8. PubMed ID: 36656202
[TBL] [Abstract] [Full Text] [Related]
20. Disease-Specific Survival Trends for Patients Presenting with Differentiated Thyroid cancer and Distant Metastases in the United States, 1992-2018.
Wilhelm A; Conroy PC; Calthorpe L; Shui AM; Kitahara CM; Roman SA; Sosa JA
Thyroid; 2023 Jan; 33(1):63-73. PubMed ID: 36413032
[No Abstract] [Full Text] [Related]
[Next]
